Literature DB >> 21653198

Prevalence of BRCA1 and BRCA2 mutations in triple negative breast cancer.

D G Evans1, A Howell, D Ward, F Lalloo, J L Jones, D M Eccles.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21653198     DOI： 10.1136/jmedgenet-2011-100006

Source DB:  PubMed          Journal:  J Med Genet        ISSN： 0022-2593            Impact factor:   6.318


× No keyword cloud information.
  35 in total

Review 1.  Neoadjuvant Therapy for Breast Cancer: Established Concepts and Emerging Strategies.

Authors:  Tessa G Steenbruggen; Mette S van Ramshorst; Marleen Kok; Sabine C Linn; Carolien H Smorenburg; Gabe S Sonke
Journal:  Drugs       Date:  2017-08       Impact factor: 9.546

2.  Breast cancer subtypes and previously established genetic risk factors: a bayesian approach.

Authors:  Katie M O'Brien; Stephen R Cole; Lawrence S Engel; Jeannette T Bensen; Charles Poole; Amy H Herring; Robert C Millikan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-10-31       Impact factor: 4.254

3.  Inherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancer.

Authors:  Fergus J Couch; Steven N Hart; Priyanka Sharma; Amanda Ewart Toland; Xianshu Wang; Penelope Miron; Janet E Olson; Andrew K Godwin; V Shane Pankratz; Curtis Olswold; Seth Slettedahl; Emily Hallberg; Lucia Guidugli; Jaime I Davila; Matthias W Beckmann; Wolfgang Janni; Brigitte Rack; Arif B Ekici; Dennis J Slamon; Irene Konstantopoulou; Florentia Fostira; Athanassios Vratimos; George Fountzilas; Liisa M Pelttari; William J Tapper; Lorraine Durcan; Simon S Cross; Robert Pilarski; Charles L Shapiro; Jennifer Klemp; Song Yao; Judy Garber; Angela Cox; Hiltrud Brauch; Christine Ambrosone; Heli Nevanlinna; Drakoulis Yannoukakos; Susan L Slager; Celine M Vachon; Diana M Eccles; Peter A Fasching
Journal:  J Clin Oncol       Date:  2014-12-01       Impact factor: 44.544

4.  Next Generation Sequencing Reveals High Prevalence of BRCA1 and BRCA2 Variants of Unknown Significance in Early-Onset Breast Cancer in African American Women.

Authors:  Luisel Ricks-Santi; J Tyson McDonald; Bert Gold; Michael Dean; Nicole Thompson; Muneer Abbas; Bradford Wilson; Yasmine Kanaan; Tammey J Naab; Georgia Dunston
Journal:  Ethn Dis       Date:  2017-04-20       Impact factor: 1.847

5.  High incidence of germline BRCA mutation in patients with ER low-positive/PR low-positive/HER-2 neu negative tumors.

Authors:  Rachel A Sanford; Juhee Song; Angelica M Gutierrez-Barrera; Jessica Profato; Ashley Woodson; Jennifer Keating Litton; Isabelle Bedrosian; Constance T Albarracin; Vicente Valero; Banu Arun
Journal:  Cancer       Date:  2015-08-17       Impact factor: 6.860

6.  Retrospective analysis of clinicopathological characteristics and family history data of early-onset breast cancer: a single-institutional study of Hungarian patients.

Authors:  Lilla Madaras; Zsuzsanna Baranyák; Janina Kulka; Attila Marcell Szász; Attila Kovács; Phan Huong Lan; Borbála Székely; Magdolna Dank; Tibor Nagy; Orsolya Kiss; László Harsányi; Tamás Barbai; István Kenessey; Anna Mária Tőkés
Journal:  Pathol Oncol Res       Date:  2013-05-26       Impact factor: 3.201

7.  Association of EP2 receptor and SLC19A3 in regulating breast cancer metastasis.

Authors:  Isabella W Cheuk; Vivian Y Shin; Man T Siu; Julia Y Tsang; John C Ho; Jiawei Chen; Gary M Tse; Xian Wang; Ava Kwong
Journal:  Am J Cancer Res       Date:  2015-10-15       Impact factor: 6.166

8.  Small interfering RNA library screen identified polo-like kinase-1 (PLK1) as a potential therapeutic target for breast cancer that uniquely eliminates tumor-initiating cells.

Authors:  Kaiji Hu; Jennifer H Law; Abbas Fotovati; Sandra E Dunn
Journal:  Breast Cancer Res       Date:  2012-02-06       Impact factor: 6.466

9.  Identification of inherited genetic variations influencing prognosis in early-onset breast cancer.

Authors:  Sajjad Rafiq; William Tapper; Andrew Collins; Sofia Khan; Ioannis Politopoulos; Sue Gerty; Carl Blomqvist; Fergus J Couch; Heli Nevanlinna; Jianjun Liu; Diana Eccles
Journal:  Cancer Res       Date:  2013-01-14       Impact factor: 12.701

10.  Clinicopathological analysis of early-stage breast cancer patients that meet indications for BRCA1/2 genetic testing.

Authors:  Hongyu Xiang; Ling Xin; Qian Liu; Hong Zhang; Shuang Zhang; Jingming Ye; Yuanjia Cheng; Ting Li; Yinhua Liu; Ling Xu
Journal:  Chin J Cancer Res       Date:  2020-04       Impact factor: 5.087
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.